Celgene to Acquire Delinia, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Celgene (CELG) PT Raised to $148 at Oppenheimer
January 26, 2017 3:32 PM ESTOppenheimer analyst Leah Rush Cann raised her price target on Celgene (NASDAQ: CELG) to $148.00 (from $141.00) while maintaining a Outperform rating.
Rush Cann commented, "Celgene reported a strong quarter and year-end that was in line with expectations. The outlook for Celgenes clinical... More
